/Investor DB

Arboretum Ventures — 2021 Investments

4 investments dated 2021 · listed companies and verified rows first · show all

Convergent Dentalconvergentdental.comin𝕏Aug 2021✓ verified

Convergent Dental is a privately owned dental equipment and technology company whose flagship product, Solea, is a CO2 all-tissue laser cleared by the FDA that offers anesthesia-free, blood-free, and suture-free dental procedures.

Enterprise SoftwareHardwareHealthtechMedical DevicesNatick, US

Nathan P. Monty(Executive Officer, Director)inMichael J. Cataldo(Executive Officer, Director)Rob Gershon(Chief Executive Officer)inMark Collins(Chief Financial Officer)inTodd Hornsby(Chief Commercial Officer)in

BoardBart Doedens(Director)

Board seatTimothy PetersenTimothy B. Petersen· per SEC Form D

Co-investorsLRVHealthTrinity Capital

Health Scholarshealthscholars.cominJun 2021 · $17M

Health Scholars (UpSkillAI) provides AI- and XR-based immersive training, using voice-powered VR simulations that let teams practice protocols hands-free.

AI & Machine LearningEdTechFuture of WorkWestminster, US

BRIAN GILLETT(Executive Officer)ROBERT SEHRING(Director)ANGELA MCFARLAND(Executive Officer)SCOTT JOHNSON(Executive Officer, Director)LAURA MEDINA(Executive Officer)RIKARD STEIBER(Director)

Board seatThomas Shehab· per SEC Form D

Co-investorsCapital Midwest FundService Provider CapitalClarevia Ventures

Rarecyterarecyte.comAug 2021 · $24M

Seattle, US

Ronald Seubert(Executive Officer, Director, Promoter)Evan Castiglia(Executive Officer)inJoseph Victor(Executive Officer, Director)Frank Witney(Director)Eric Kaldjian(Executive Officer)

BoardRobert Shepler(Director)in

Board seatJan Garfinkle· per SEC Form D

Co-investors5AM VenturesF-Prime CapitalTelegraph Hill PartnersHealthQuest CapitalSofinnova Ventures

EQRxeqrx.comJan 2021Acquired

EQRx was a Cambridge, MA biopharma that aimed to sell lower-priced novel drugs; it was acquired by Revolution Medicines in 2023.

Alexis Borisy(Founder)

Co-investorsAndreessen HorowitzARCH Venture PartnersGV (Google Ventures)Nextech InvestBain CapitalCasdin Capital+1 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.